Instrument | Measure | Total | Much better | A little better | About the same | A little worse | Worse | |
---|---|---|---|---|---|---|---|---|
OHS | (N = 181,424) | (N = 155,899) | (N = 15,565) | (N = 3891) | (N = 2382) | (N = 1633) | ||
Observed | 51% | 58% | 10% | 4% | 1% | 1% | ||
AUCa | 0.8 | 0.8 | 0.8 | 0.8 | 0.7 | 0.8 | ||
Predicted | Pre-op. | 53% | 62% | - | - | - | - | |
Pre-op., age, gender, comorbidity | 54% | 62% | - | - | - | - | ||
EQ-5D-3L | (N = 171,423) | (N = 147,638) | (N = 14,577) | (N = 3625) | (N = 2216) | (N = 1493) | ||
Observed | 44% | 46% | 39% | 29% | 21% | 13% | ||
AUC | 0.9 | 0.9 | 0.9 | 0.8 | 0.8 | 0.7 | ||
Predicted | Pre-op. | 48% | 47% | 43% | 11% | 4% | 6% | |
Pre-op., age, gender, comorbidity | 48% | 47% | 41% | 11% | 4% | 6% |